Dyslipidemia Essentials

Atherosclerotic vascular disease is one of the leading cause of morbidity and mortality worldwide, accounting for more than one-third of all deaths each year. High cholesterol is the most prevalent and important modifiable risk factor for atherosclerosis, affecting one in two (100 million) U.S. adults and hundreds of millions of people more worldwide. Proper treatment reduces the risk of cardiac death, nonfatal myocardial infarction, stroke, revascularization procedures, and peripheral arterial disease by 25-80%. Despite these benefits, only 20% of adults meet national guidelines, and thousands of lives are lost each year from failure to implement established measures. Dyslipidemia Essentials integrates the latest clinical guidelines and trials into a concise, authoritative, and practical step-by-step guide to the management of dyslipidemia. Important clinical trials, common management pitfalls, and other cardiovascular risk reduction measures are also emphasized.